Predictions
Myovant Sciences Ltd
Start price
Target price
Perf. (%)
€17.50
19.08.22
19.08.22
-
19.08.23
19.08.23
-4.00%
26.08.22
26.08.22
Could be very worthwhile Investment >20% year
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.29
18.08.22
18.08.22
€7.00
18.08.23
18.08.23
-33.11%
22.08.22
22.08.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth >5% per year expected
Crossject S.A.
Start price
Target price
Perf. (%)
€4.71
16.08.22
16.08.22
€5.00
16.08.23
16.08.23
-14.13%
12.11.22
12.11.22
Could be worthwhile Investment >10% per year
ShockWave Medical Inc
Start price
Target price
Perf. (%)
€288.60
16.08.22
16.08.22
-
16.08.23
16.08.23
-29.14%
16.08.23
16.08.23
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€24.20
16.08.22
16.08.22
-
16.08.23
16.08.23
-4.96%
16.08.23
16.08.23
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.50
16.08.22
16.08.22
-
16.08.23
16.08.23
-27.77%
16.08.23
16.08.23
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€104.86
16.08.22
16.08.22
-
16.08.23
16.08.23
-6.73%
16.08.23
16.08.23
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€94.03
16.08.22
16.08.22
-
16.08.23
16.08.23
-11.99%
16.08.23
16.08.23
Seagen Inc.
Start price
Target price
Perf. (%)
€165.90
15.08.22
15.08.22
€180.00
31.01.24
31.01.24
9.64%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.91
13.08.22
13.08.22
€1.00
13.08.23
13.08.23
-12.70%
23.08.22
23.08.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Mediwound Ltd.
Start price
Target price
Perf. (%)
€1.97
13.08.22
13.08.22
€5.00
13.08.23
13.08.23
-6.09%
04.09.22
04.09.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Redhill Biopharma Ltd ADR
Start price
Target price
Perf. (%)
€1.06
13.08.22
13.08.22
€7.20
13.08.23
13.08.23
-13.55%
23.08.22
23.08.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
Mediwound Ltd.
Start price
Target price
Perf. (%)
€1.97
13.08.22
13.08.22
€14.00
13.08.23
13.08.23
1.02%
22.08.22
22.08.22
Very Future proof/growth oriented business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Sanofi S.A.
Start price
Target price
Perf. (%)
€79.94
11.08.22
11.08.22
€63.00
30.09.24
30.09.24
26.47%
08.05.23
08.05.23
Could be worthwhile Investment >10% per year
Sanofi S.A.
Start price
Target price
Perf. (%)
€79.36
11.08.22
11.08.22
€110.00
11.08.23
11.08.23
22.37%
12.08.23
12.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€64.36
10.08.22
10.08.22
-
10.08.23
10.08.23
6.49%
10.08.23
10.08.23
Dynavax Technologies Corp
Start price
Target price
Perf. (%)
€15.99
10.08.22
10.08.22
-
10.08.23
10.08.23
-18.71%
10.08.23
10.08.23
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.10
10.08.22
10.08.22
-
10.08.23
10.08.23
3.34%
10.08.23
10.08.23
Valneva SE
Start price
Target price
Perf. (%)
€10.23
09.08.22
09.08.22
€14.00
09.08.23
09.08.23
-46.91%
30.05.23
30.05.23
Small cyclical dependencies
Below average Marketposition
Few uniques
Aphria Inc.
Start price
Target price
Perf. (%)
€12.71
08.08.22
08.08.22
-
08.08.26
08.08.26
-
11.03.24
11.03.24
Could be worthwhile Investment >10% per year
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€100.76
08.08.22
08.08.22
€120.00
08.08.23
08.08.23
69.31%
09.08.23
09.08.23